CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity

Experimental Dermatology

Volumn 17, Issue 1, 2008, Pages 30-34

  Mirshahpanah, Parham ^a,b   Li, Yi Yang Yvonne ^b   Burkhardt, Nicole ^a   Asadullah, Khusru ^a   Zollner, Thomas M ^a  

^a BAYER PHARMA AG   (Germany)

^b BAYER CORPORATION   (United States)

Author keywords

CCL 17 (TARC); CCL22 (MDC); CCL27 (CTACK, ALP, ESkine; Eczema; Inflammation; Leukocyte; Psoriasis; Skin homing

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; TRIMELLITIC ANHYDRIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CELL POLARITY; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; LIGAND BINDING; MONOTHERAPY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN DETERMINATION; RECEPTOR BLOCKING; SKIN EDEMA; SKIN INFLAMMATION;

ANIMALS; ANTIBODIES, MONOCLONAL; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; EDEMA; GRANULOCYTES; LEUKOCYTES; MICE; MICE, INBRED BALB C; NEUTROPHILS; PHTHALIC ANHYDRIDES; RANDOM ALLOCATION; RECEPTORS, CCR10; RECEPTORS, CCR4; SKIN; T-LYMPHOCYTES;

EID: 37248999783     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00630.x     Document Type: Article

References (31)

1. Butcher E C, Picker L J. Lymphocyte homing and homeostasis. Science 1996: 272: 60-66.
2. Springer T A. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994: 76: 301-314.
3. Zollner T M, Asadullah K, Schon M P. Targeting leukocyte trafficking to inflamed skin: Still an attractive therapeutic approach? Exp Dermatol 2007: 16: 1-12.
4. Schon M P, Ludwig R J. Lymphocyte trafficking to inflamed skin-molecular mechanisms and implications for therapeutic target molecules. Expert Opin Ther Targets 2005: 9: 225-243.
5. Reiss Y, Proudfoot A E, Power C A, Campbell J J, Butcher E C. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001: 194: 1541-1547.
6. Meller S, Lauerma A I, Kopp F M et al. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: Memory T cells make the difference. J Allergy Clin Immunol 2007: 119: 1470 -1480.
7. Vestergaard C, Deleuran M, Gesser B, Gronhoj Larsen C. Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin. Br J Dermatol 2003: 149: 457-463.
8. Lebwohl M. Psoriasis. Lancet 2003: 361: 1197-1204.
9. Wakugawa M, Nakamura K, Kakinuma T, Onai N, Matsushima K, Tamaki K. CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 2001: 117: 188-196.
10. Nakatani T, Kaburagi Y, Shimada Y et al. CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 2001: 107: 353-358.
11. Horikawa T, Nakayama T, Hikita I et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 2002: 14: 767-773.
12. Fujisawa T, Fujisawa R, Kato Y et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002: 110: 139-146.
13. Kakinuma T, Saeki H, Tsunemi Y et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003: 111: 592-597.
14. Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002: 8: 157-165.
15. Sebastiani S, Albanesi C, Nasorri F, Girolomoni G, Cavani A. Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis. J Invest Dermatol 2002: 118: 1052-1058.
16. Tsunemi Y, Saeki H, Nakamura K et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol 2006: 36: 2116-2127.
17. Kanda N, Koike S, Watanabe S. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J Allergy Clin Immunol 2005: 116: 1144-1150.
18. Moed H, Boorsma D M, Tensen C P et al. Increased CCL27-CCR10 expression in allergic contact dermatitis: Implications for local skin memory. J Pathol 2004: 204: 39-46.
19. Teraki Y, Miyake A, Takebayashi R, Shiohara T. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 2004: 29: 658-663.
20. Rottman J B, Smith T L, Ganley K G, Kikuchi T, Krueger J G. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001: 81: 335-347.
21. Kim C H, Rott L, Kunkel E J et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001: 108: 1331-1339.
22. Alferink J, Lieberam I, Reindl W et al. Compartmentalized production of CCL17 in vivo: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med 2003: 197: 585-599.
23. Dearman R J, Basketter D A, Kimber I. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice. Toxicol Appl Pharmacol 1996: 138: 308-316.
24. Dearman R J, Filby A, Humphreys I R, Kimber I. Interleukins 5 and 13 characterize immune responses to respiratory sensitizing acid anhydrides. J Appl Toxicol 2002: 22: 317-325.
25. Xu H, DiIulio N A, Fairchild R L. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: Interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996: 183: 1001-1012.
26. Schottelius A J, Giesen C, Asadullah K et al. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J Immunol 2002: 169: 7063-7070.
27. Biedermann T, Kneilling M, Mailhammer R et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000: 192: 1441-1452.
28. Grewe M, Bruijnzeel-Koomen C A, Schopf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998: 19: 359-361.
29. Marvin J S, Zhu Z. Bispecific antibodies for dual-modality cancer therapy: Killing two signaling cascades with one stone. Curr Opin Drug Discov Dev 2006: 9: 184-193.
30. Lum L G, Davol P A, Lee R J. The new face of bispecific antibodies: targeting cancer and much more. Exp Hematol 2006: 34: 1-6.
31. Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 2006: 118: 1082-1089.